Encountering opsonized particles by neutrophils results in phagocytosis of the particle and generation of extracellular vesicles with antibacterial property (aEV).
Ákos M. Lőrincz +5 more
doaj +1 more source
Atherosclerosis: Intervening in the early stages of plaque formation Researchers have identified a possible new tool, the signaling molecule SIRT1, to fight vascular diseases such as atherosclerosis, hardening of the arteries.
Seung Jin Lee +3 more
doaj +1 more source
The Role of Hypothalamic Inflammation in Dim Light at Night and High Fat Diet Induced Metabolic Disturbance [PDF]
The prevalence of obesity and metabolic disorders is rapidly increasing worldwide. This increase in metabolic dysfunction correlates with increased exposure to artificial light at night (LAN).
Lieberman, Rebecca
core
HTRF-based assay for detection of mono-ADP-ribosyl hydrolyzing macrodomains and inhibitor screening
Summary: The COVID-19 pandemic has highlighted the lack of effective, ready-to-use antivirals for the treatment of viruses with pandemic potential. The development of a diverse drug portfolio is therefore crucial for pandemic preparedness.
Niklas Ildefeld +3 more
doaj +1 more source
Efficient Binding Affinity Estimation for Fragment-Based Compounds Using a Separated Topologies Approach. [PDF]
Caldaruse AM, Baumann HM, Mobley DL.
europepmc +1 more source
Evolution of distinct subclones in a CALM-AF10-driven AML murine model results in leukemias with different phenotypes. [PDF]
Zandvakili N +6 more
europepmc +1 more source
Rewriting the viral script: post-translational modifications orchestrating SARS-CoV-2 pathogenesis and immune evasion. [PDF]
Qu J, Liu M, Zhou C.
europepmc +1 more source
Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer [PDF]
Bresnick, Emery H +12 more
core +1 more source
Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy In Vivo. [PDF]
Jaishankar P +18 more
europepmc +1 more source
CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2. [PDF]
Herasymenko O +82 more
europepmc +1 more source

